Brief description of trial (Data source: BASEC)
Lo studio si prefigge di appurare per quanto tempo il robot per la riabilitazione della mano “ReHapticKnob” possa essere usato in modo autonomo all’interno di un centro di riabilitazione e se il dispositivo sia facile da usare.
Con il “ReHapticKnob” vengono eseguiti esercizi che allenano le funzioni motorie e sensoriali della mano in pazienti cha hanno subito un ictus cerebrale.
In particolare, durante questo studio vogliamo determinare se i partecipanti possono imparare a svolgere da soli gli esercizi con il robot “ReHapticKnob”, in modo da potersi esercitare anche autonomamente. Vogliamo testare se il robot è facile da usare e per quanto tempo i pazienti lo usano senza la supervisione di un terapista.
I partecipanti avranno due settimane di tempo per imparare ad utilizzare il robot con l'aiuto di un terapista. Dopo questa fase di allenamento, se ritenuti pronti, i partecipanti potranno svolgere gli esercizi anche senza la presenza di un terapista.
In questo modo, i pazienti potranno allenarsi di più, potenzialmente migliorando ulteriormente le funzionalità della mano lesa, e questo senza aumentare in modo eccessivo il carico di lavoro dei terapisti.
Health conditions investigated(Data source: BASEC)
Ictus cerebrale
Health conditions
(Data source: WHO)
Stroke
Rare disease
(Data source: BASEC)
No
Intervention investigated (e.g. drug, therapy or campaign)
(Data source: BASEC)
In questo studio viene esaminata l'esecuzione indipendente degli esercizi con il robot per la riabilitazione della mano ReHapticKnob. Con esecuzione indipendente si intende che il paziente si allena con l'aiuto del robot senza la supervisione diretta di un terapista.
Interventions
(Data source: WHO)
Device: Minimally supervised therapy with the ReHapticKnob
Criteria for participation in trial
(Data source: BASEC)
1. Fase acuta/subacuta dell'ictus cerebrale, ovvero entro 6 settimane dall’ictus.
2. NIHSS ≥ 1 in almeno uno dei campi riguardanti funzioni motorie, sensoriali o atassia.
3. Pre-stroke modified rankin score (pre-mRS) ≤ 1.
Exclusion criteria
(Data source: BASEC)
1. Afasia moderata o grave: Goodglass-Kaplan scale < 3.
2. Deficit cognitivi moderati o gravi: LCF-R < 8.
3. Forti dolori nell’arto superiore paretico: VASp ≥ 5.
Inclusion/Exclusion Criteria
(Data source: WHO)
Gender: All
Maximum age: 90 Years
Minimum age: 18 Years
Inclusion Criteria:
- Male and female stroke patients between 18 and 90 years old;
- pre-stroke Modified Rankin Score = 1;
- acute/subacute stroke (within (=) 6 weeks from onset);
- NIHSS = 1 in at least one of the items regarding motor function, sensory functions and
ataxia;
- the patient read, understood and signed the informed consent.
Exclusion Criteria:
- Modified Ashworth Scale > 2 for one or more of the following muscles: shoulder
adductors, forearm pronator and supinator, flexors and extensors of elbow, wrist and
fingers;
- moderate to severe aphasia: Goodglass-Kaplan scale < 3;
- moderate to severe cognitive deficits: levels of cognitive functioning-revised (LCF-R)
< 8;
- functional impairment of the upper limb due to other pathologies;
- severe pain in the affected arm: visual analogue scale for pain (VASp) = 5;
- other pathologies which may interfere with the study;
- pacemakers and other active implants.
-
Further information on trial
Recruitment status
Completed
Academic title
(Data source: WHO)
Clinical Feasibility of Minimally Supervised Therapy After Stroke With a Hand Rehabilitation Robot (ReHapticKnob): Pilot and Main Study
Type of trial
(Data source: WHO)
Interventional
Design of the trial
(Data source: WHO)
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
Phase
(Data source: WHO)
N/A
Primary end point
(Data source: WHO)
Compliance as assessed by dose
Secundary end point
(Data source: WHO)
Usability as assessed by the Post-Study System Usability Questionnaire;Usability as assessed by the System Usability Scale;Usability as assessed by the NASA Task Load Index;Evolution of patient's satisfaction with robot-assisted therapy as assessed by a 5-point scale;Change in upper limb functions as assessed by the Fugl-Meyer Assessment of Upper Extremities (FMA-UE);Change in upper limb functions as assessed by the ABILHAND;Change in upper limb functions as assessed by the Box and Block (BBT) test;Change in upper limb functions as assessed by the Motor Evaluation Scale for Upper Extremities in Stroke Patients (MESUPES);Change in upper limb functions as assessed by the modified Ashworth Scale (mAS);Change in the active Range of Motion (aROM) for grasping as assessed by a custom robotic assessment;Change in the active Range of Motion (aROM) for forearm rotation as assessed by a custom robotic assessment;Change in hand proprioception as assessed by a custom robotic assessment measuring the minimum difference in length that a patient can perceive;Change in haptic perception as assessed by a custom robotic assessment measuring the minimum difference in stiffness that a patient can perceive;Monitoring of muscle tone;Change in knowledge about stroke and health as assessed by a custom questionnaire consisting of 20 open or multiple-choice questions about stroke and health
Contact information
(Data source: WHO)
Please refer to primary and secondary sponsors
Trial results
(Data source: WHO)
Results summary
no information available yet
Link to the results in the primary register
no information available yet
Information on the availability of individual participant data
no information available yet
Trial sites
Trial sites in Switzerland
(Data source: BASEC)
Brissago
Countries
(Data source: WHO)
Switzerland
Contact for further information on the trial
Details of contact in Switzerland
(Data source: BASEC)
Giada Devittori
+41 44 510 72 31
giada.devittori@hest.ethz.ch
Contact for general information
(Data source: WHO)
Paolo Rossi, Dr. med.
CLINICA HILDEBRAND CENTRO DI RIABILITAZIONE BRISSAGO
Contact for scientific information
(Data source: WHO)
Paolo Rossi, Dr. med.
CLINICA HILDEBRAND CENTRO DI RIABILITAZIONE BRISSAGO
Authorisation by the ethics committee (Data source: BASEC)
Name of the authorising ethics committee (for multicentre studies only the lead committee)
Comitato etico cantonale Ticino
Date of authorisation by the ethics committee
24.02.2020
Further trial identification numbers
Trial identification number of the ethics committee (BASEC-ID)
(Data source: BASEC)
2020-00179
Secondary ID (Data source: WHO)
ReHapticKnob 2020
Back to overview
